Atlas Trials

Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes

Clinical trial NCT04262479 · COMPLETED

Trial details

NCT number
NCT04262479
Sponsor
Norwegian University of Science and Technology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Latent Autoimmune Diabetes in Adults
Start date
2020-03-02
Primary completion
2022-05-05
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.